Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. uri icon

authors

  • Gerstein, Hertzel C
  • Rydén, Lars
  • Xavier, Denis
  • Atisso, Charles Messan
  • Dyal, Leanne
  • Hall, Stephanie
  • Rao-Melacini, Purnima
  • Wong, Gloria
  • Avezum, Alvaro
  • Basile, Jan
  • Chung, Namsik
  • Colhoun, Helen M
  • Conget, Ignacio
  • Cushman, William C
  • Franek, Edward
  • Hancu, Nicolae
  • Hanefeld, Markolf
  • Holt, Shaun
  • Jansky, Petr
  • Keltai, Matyas
  • Lanas, Fernando
  • Leiter, Lawrence A
  • Dagenais, Gilles R
  • Lopez-Jaramillo, Patricio
  • Cardona Munoz, Ernesto German
  • Pirags, Valdis
  • Pogosova, Nana
  • Raubenheimer, Peter J
  • Shaw, Jonathan E
  • Sheu, Wayne H-H
  • Temelkova-Kurktschiev, Theodora
  • Diaz, Rafael
  • Lakshmanan, Mark
  • Pais, Prem
  • Probstfield, Jeffrey
  • Riesmeyer, Jeffrey S
  • Riddle, Matthew C

publication date

  • June 9, 2019